{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:31:51Z","timestamp":1793457111964,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11102-026-01748-9","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:56:16Z","timestamp":1787230576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Soluble alpha-klotho as an adjunct biomarker of disease activity in acromegaly: Added value beyond GH and IGF-1"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7247-5492","authenticated-orcid":false,"given":"Vivek","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6241-3033","authenticated-orcid":false,"given":"Sanja","family":"Medenica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9375-3102","authenticated-orcid":false,"given":"Naresh","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3029-4544","authenticated-orcid":false,"given":"Vaishali","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5415-1611","authenticated-orcid":false,"given":"Pinaki","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"19","key":"1748_CR1","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMra2409076","volume":"393","author":"A Giustina","year":"2025","unstructured":"Giustina A, Colao A, Acromegaly (2025) N Engl J Med 393(19):1926\u20131939","journal-title":"N Engl J Med"},{"issue":"Supplement1","key":"1748_CR2","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1210\/clinem\/dgag114","volume":"111","author":"A Giustina","year":"2026","unstructured":"Giustina A, Fleseriu M (2026) Acromegaly complications: an update. J Clin Endocrinol Metab 111(Supplement1):S51\u2013s63","journal-title":"J Clin Endocrinol Metab"},{"key":"1748_CR3","doi-asserted-by":"crossref","unstructured":"Katznelson L, Laws ER Jr., Melmed S, Molitch ME, Murad MH, Utz A et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u201351","DOI":"10.1210\/jc.2014-2700"},{"issue":"1","key":"1748_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/er.2018-00115","volume":"40","author":"MR Gadelha","year":"2019","unstructured":"Gadelha MR, Kasuki L, Lim DST, Fleseriu M (2019) Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update. Endocr Rev 40(1):268\u2013332","journal-title":"Endocr Rev"},{"issue":"1","key":"1748_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","volume":"27","author":"A Giustina","year":"2024","unstructured":"Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C et al (2024) Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27(1):7\u201322","journal-title":"Pituitary"},{"issue":"5","key":"1748_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm10051147","volume":"10","author":"A Akirov","year":"2021","unstructured":"Akirov A, Masri-Iraqi H, Dotan I, Shimon I (2021) The biochemical diagnosis of acromegaly. J Clin Med 10(5):1\u20138","journal-title":"J Clin Med"},{"issue":"2","key":"1748_CR7","first-page":"41","volume":"26","author":"EM Lim","year":"2005","unstructured":"Lim EM, Pullan P (2005) Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society. Clin Biochem Rev 26(2):41\u201343","journal-title":"Clin Biochem Rev"},{"issue":"2","key":"1748_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1365-2265.2009.03556.x","volume":"71","author":"PU Freda","year":"2009","unstructured":"Freda PU (2009) Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clin Endocrinol (Oxf) 71(2):166\u2013170","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1748_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.arr.2008.10.002","volume":"8","author":"Y Wang","year":"2009","unstructured":"Wang Y, Sun Z (2009) Current understanding of klotho. Ageing Res Rev 8(1):43\u201351","journal-title":"Ageing Res Rev"},{"issue":"1","key":"1748_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2796.2012.02542.x","volume":"272","author":"L Sze","year":"2012","unstructured":"Sze L, Bernays RL, Zwimpfer C, Wiesli P, Br\u00e4ndle M, Schmid C (2012) Excessively high soluble Klotho in patients with acromegaly. J Intern Med 272(1):93\u201397","journal-title":"J Intern Med"},{"issue":"1","key":"1748_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.5114\/aoms.2014.45050","volume":"12","author":"AM D\u0105browska","year":"2016","unstructured":"D\u0105browska AM, Tarach JS (2016) Soluble Klotho protein as a novel serum biomarker in patients with acromegaly. Arch Med Sci 12(1):222\u2013226","journal-title":"Arch Med Sci"},{"issue":"4","key":"1748_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1530\/EJE-12-1045","volume":"168","author":"MC Neidert","year":"2013","unstructured":"Neidert MC, Sze L, Zwimpfer C, Sarnthein J, Seifert B, Frei K et al (2013) Soluble \u03b1-klotho: a novel serum biomarker for the activity of GH-producing pituitary adenomas. Eur J Endocrinol 168(4):575\u2013583","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1748_CR13","doi-asserted-by":"publisher","first-page":"e2887","DOI":"10.1210\/clinem\/dgab257","volume":"106","author":"J Schweizer","year":"2021","unstructured":"Schweizer J, Schilbach K, Haenelt M, Giannetti AV, Bizzi MF, Soares BS et al (2021) Soluble Alpha Klotho in Acromegaly: Comparison With Traditional Markers of Disease Activity. J Clin Endocrinol Metab 106(8):e2887\u2013e99","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1748_CR14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/ejendo\/lvaf093","volume":"192","author":"J Schweizer","year":"2025","unstructured":"Schweizer J, Schilbach K, Haenelt M, Gagliardo A, Peters A, Thorand B et al (2025) Soluble alpha klotho-impact of biological variables and reference intervals for adults. Eur J Endocrinol 192(5):631\u2013640","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"1748_CR15","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41574-025-01148-2","volume":"21","author":"S Melmed","year":"2025","unstructured":"Melmed S, di Filippo L, Fleseriu M, Mercado M, Karavitaki N, Gurnell M et al (2025) Consensus on acromegaly therapeutic outcomes: an update. Nat Reviews Endocrinol 21(11):718\u2013737","journal-title":"Nat Reviews Endocrinol"},{"key":"1748_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1266339","volume":"14","author":"DR Clemmons","year":"2023","unstructured":"Clemmons DR, Bidlingmaier M (2023) Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly. Front Endocrinol (Lausanne) 14:1266339","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1748_CR17","doi-asserted-by":"crossref","unstructured":"Riley RD, Ensor J, Snell KIE, Harrell FE Jr., Martin GP, Reitsma JB et al (2020) Calculating the sample size required for developing a clinical prediction model. BMJ 368:m441","DOI":"10.1136\/bmj.m441"},{"issue":"9","key":"1748_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","volume":"14","author":"S Melmed","year":"2018","unstructured":"Melmed S, Bronstein MD, Chanson P, Klibanski A, Casanueva FF, Wass JAH et al (2018) A Consensus Statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14(9):552\u2013561","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"1748_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1210\/clinem\/dgaa859","volume":"106","author":"C Campana","year":"2021","unstructured":"Campana C, Cocchiara F, Corica G, Nista F, Arvigo M, Amar\u00f9 J et al (2021) Discordant GH and IGF-1 Results in Treated Acromegaly: Impact of GH Cutoffs and Mean Values Assessment. J Clin Endocrinol Metab 106(3):789\u2013801","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1748_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/cen.12385","volume":"80","author":"L Sze","year":"2014","unstructured":"Sze L, Neidert MC, Bernays RL, Zwimpfer C, Wiesli P, Haile SR et al (2014) Gender dependence of serum soluble Klotho in acromegaly. Clin Endocrinol (Oxf) 80(6):869\u2013873","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1748_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1530\/EC-14-0028","volume":"3","author":"AJ Varewijck","year":"2014","unstructured":"Varewijck AJ, van der Lely AJ, Neggers SJ, Lamberts SW, Hofland LJ, Janssen JA (2014) In active acromegaly, IGF1 bioactivity is related to soluble Klotho levels and quality of life. Endocr Connect 3(2):85\u201392","journal-title":"Endocr Connect"},{"issue":"4","key":"1748_CR22","first-page":"390","volume":"67","author":"A Jawiarczyk-Przyby\u0142owska","year":"2016","unstructured":"Jawiarczyk-Przyby\u0142owska A, Halupczok-\u017by\u0142a J, Bolanowski M (2016) Soluble \u03b1-Klotho - a new marker of acromegaly? Endokrynol Pol 67(4):390\u2013396","journal-title":"Endokrynol Pol"},{"issue":"4","key":"1748_CR23","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/cen.14380","volume":"94","author":"N Helvaci","year":"2021","unstructured":"Helvaci N, Kabacam S, Dagdelen S, Lay I, Karabulut E, Mut M et al (2021) Klotho gene G395A and C1818T polymorphisms in acromegaly: association with clinical presentation and comorbidities. Clin Endocrinol (Oxf) 94(4):598\u2013605","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1748_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19078-8","volume":"12","author":"MC Neidert","year":"2022","unstructured":"Neidert MC, Zeitlberger AM, Leske H, Tschopp O, Sze L, Zwimpfer C et al (2022) Association of pre- and postoperative \u03b1Klotho levels with long-term remission after pituitary surgery for acromegaly. Sci Rep 12(1):14765","journal-title":"Sci Rep"},{"issue":"1","key":"1748_CR25","doi-asserted-by":"publisher","first-page":"bvaf207","DOI":"10.1210\/jendso\/bvaf207","volume":"10","author":"D Tanioka","year":"2026","unstructured":"Tanioka D, Natori I, Kobayashi Y, Arai S, Matsumoto M, Sumi K et al (2026) Early Postoperative Predictors of Remission After Transsphenoidal Surgery in Acromegaly: Introduction of the PARS. J Endocr Soc 10(1):bvaf207","journal-title":"J Endocr Soc"},{"issue":"3","key":"1748_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1055\/a-2319-0344","volume":"86","author":"NE Cetinalp","year":"2025","unstructured":"Cetinalp NE, Akkus G, Seydaoglu G, Ozsoy KM, Akbaba M, Baykara O et al (2025) Early Predictors of Remission in Acromegaly Patients after Pure Endoscopic Endonasal Transsphenoidal Surgery. J Neurol Surg B Skull Base 86(3):303\u2013312","journal-title":"J Neurol Surg B Skull Base"},{"issue":"6","key":"1748_CR27","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1210\/clinem\/dgab069","volume":"106","author":"EC Coopmans","year":"2021","unstructured":"Coopmans EC, Postma MR, Wolters TLC, van Meyel SWF, Netea-Maier R, van Beek AP et al (2021) Predictors for Remission after Transsphenoidal Surgery in Acromegaly: A Dutch Multicenter Study. J Clin Endocrinol Metab 106(6):1783\u20131792","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1748_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11102-025-01503-6","volume":"28","author":"A Pennlund","year":"2025","unstructured":"Pennlund A, Esposito D, Bontell TO, Skoglund T, Hall\u00e9n T, Car\u00e9n H et al (2025) Long-term clinical outcome of 103 patients with acromegaly after pituitary surgery. Pituitary 28(2):33","journal-title":"Pituitary"},{"issue":"11","key":"1748_CR29","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S2213-8587(22)00244-3","volume":"10","author":"M Fleseriu","year":"2022","unstructured":"Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S (2022) Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 10(11):804\u2013826","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"1748_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11102-017-0797-7","volume":"20","author":"R Pivonello","year":"2017","unstructured":"Pivonello R, Auriemma RS, Grasso LF, Pivonello C, Simeoli C, Patalano R et al (2017) Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary 20(1):46\u201362","journal-title":"Pituitary"},{"issue":"1","key":"1748_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102\u2013152","journal-title":"Endocr Rev"},{"issue":"3","key":"1748_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4183\/aeb.2018.365","volume":"14","author":"\u0141 Mizera","year":"2018","unstructured":"Mizera \u0141, Elbaum M, Daroszewski J, Bolanowski M (2018) CARDIOVASCULAR COMPLICATIONS OF ACROMEGALY. Acta Endocrinol (Buchar) 14(3):365\u2013374","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"9","key":"1748_CR33","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1210\/clinem\/dgac400","volume":"107","author":"D Esposito","year":"2022","unstructured":"Esposito D, Olsson DS, Franz\u00e9n S, Miftaraj M, N\u00e5tman J, Gudbj\u00f6rnsdottir S et al (2022) Effect of Diabetes on Morbidity and Mortality in Patients With Acromegaly. J Clin Endocrinol Metab 107(9):2483\u20132492","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1748_CR34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11154-020-09560-x","volume":"21","author":"TLC Wolters","year":"2020","unstructured":"Wolters TLC, Netea MG, Riksen NP, Hermus A, Netea-Maier RT (2020) Acromegaly, inflammation and cardiovascular disease: a review. Rev Endocr Metab Disord 21(4):547\u2013568","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"1748_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11102-026-01639-z","volume":"29","author":"A Giustina","year":"2026","unstructured":"Giustina A, di Filippo L, Fleseriu M, Pivonello R, Petersenn S, Wass J et al (2026) Consensus on acromegaly complications: an update. Pituitary 29(3):76","journal-title":"Pituitary"},{"issue":"11","key":"1748_CR36","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrneph.2013.111","volume":"9","author":"M Kuro-o","year":"2013","unstructured":"Kuro-o M (2013) Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism. Nat Rev Nephrol 9(11):650\u2013660","journal-title":"Nat Rev Nephrol"},{"key":"1748_CR37","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-030212-183727","volume":"75","author":"MC Hu","year":"2013","unstructured":"Hu MC, Shiizaki K, Kuro-o M, Moe OW (2013) Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol 75:503\u2013533","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"1748_CR38","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11102-024-01397-w","volume":"27","author":"A Giustina","year":"2024","unstructured":"Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P et al (2024) Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE). Pituitary 27(4):381\u2013388","journal-title":"Pituitary"},{"issue":"5","key":"1748_CR39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11102-017-0838-2","volume":"20","author":"FF Casanueva","year":"2017","unstructured":"Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS et al (2017) Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement. Pituitary 20(5):489\u2013498","journal-title":"Pituitary"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01748-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01748-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01748-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:11:47Z","timestamp":1793455907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01748-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1748"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01748-9","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"5 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Ethics Committee, Postgraduate Institute of Medical Education and Research, Chandigarh, India (Reference No. IEC-07\/2020\u2009\u2212\u20091715), and was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from participants as per institutional guidelines.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI-assisted language editing tools were used only to improve grammar and readability. All scientific content, data analysis, interpretation, and final manuscript decisions were performed and verified by the authors, who take full responsibility for the integrity and accuracy of the work.","order":4,"name":"Ethics","label":"<b>Use of AI tools<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"144"}}